A curated reference for every compound in our catalogue — mechanism of action, molecular data, half-life and documented research areas.
Triple agonist of GLP-1, GIP and glucagon receptors investigated for advanced metabolic and body-weight research.
Triple agonist of GLP-1, GIP and glucagon receptors investigated for advanced metabolic and body-weight research.
Dual incretin agonist targeting GLP-1 and GIP receptors, widely studied across glycaemic and weight-management protocols.
Dual incretin agonist targeting GLP-1 and GIP receptors, widely studied across glycaemic and weight-management protocols.
GLP-1 receptor agonist used extensively across weight, appetite and glycaemic research.
Long-acting amylin analog studied alongside GLP-1 agonists for compounded metabolic effects.
Research blend of Cagrilintide and Retatrutide investigated in advanced metabolic protocols.
Research blend of Cagrilintide and Retatrutide investigated in advanced metabolic protocols.
Research blend of Cagrilintide and Tirzepatide investigated in combined metabolic protocols.
Research blend of Cagrilintide and Tirzepatide investigated in combined metabolic protocols.
Research blend of Cagrilintide and Semaglutide investigated for compounded metabolic effects.
Dual-peptide research blend combining BPC-157 and TB-500 for compounded regenerative studies.
Activin-binding protein studied for its role in myostatin inhibition and muscle-growth research.
Mitochondrial-derived peptide investigated across longevity, insulin sensitivity and metabolic signalling.
Synthetic tetrapeptide studied for effects on telomerase expression and circadian regulation.
Coenzyme investigated for its role in cellular energy metabolism and mitochondrial function research.
Growth-hormone-releasing hormone analog used to study endocrine and pituitary signalling.
Stabilised GHRH analog investigated for visceral-adipose and metabolic research.
Recombinant human growth hormone studied in endocrine, metabolic and tissue-growth research.
Synthetic ACTH-derived peptide studied for neurotrophic and cognitive-support research.
Synthetic analog of tuftsin studied for anxiolytic and immunomodulatory research.
Nonapeptide studied for its proposed role in sleep regulation and stress-response research.
Synthetic α-MSH analog studied in pigmentation, appetite and behavioural research.
Copper-binding tripeptide investigated for skin remodelling and wound-repair research.
Copper-binding tripeptide analog related to GHK-Cu, investigated for skin remodelling and wound-repair research.
Research blend marketed for skin- and recovery-focused protocols. See product page for full composition.
Research blend marketed for skin- and glow-focused protocols. See product page for full composition.
Research compound available in our catalogue. See product page for full details and composition.
No compounds match your search or filter.
Research Use Only. All information published in the Prime Peptides library is provided strictly for in-vitro laboratory research and informational purposes. Compounds are not intended for human or veterinary use and are not for the diagnosis, treatment or prevention of disease.